Davis R M Inc. Has $20.91 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

Davis R M Inc. reduced its position in shares of CME Group Inc. (NASDAQ:CME) by 5.1% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 94,766 shares of the financial services provider’s stock after selling 5,128 shares during the quarter. Davis R M Inc.’s holdings in CME Group were worth $20,910,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in CME. Harbor Capital Advisors Inc. boosted its holdings in CME Group by 0.6% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock valued at $1,723,000 after purchasing an additional 45 shares during the period. CVA Family Office LLC raised its holdings in shares of CME Group by 11.8% during the 3rd quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock valued at $96,000 after buying an additional 46 shares in the last quarter. Lester Murray Antman dba SimplyRich lifted its position in CME Group by 0.7% in the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after buying an additional 50 shares during the last quarter. Zions Bancorporation N.A. boosted its stake in CME Group by 3.7% in the third quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider’s stock worth $338,000 after buying an additional 54 shares in the last quarter. Finally, Quent Capital LLC grew its position in CME Group by 10.2% during the third quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock valued at $131,000 after acquiring an additional 55 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

Insider Activity

In other news, Director Martin J. Gepsman sold 400 shares of CME Group stock in a transaction on Monday, November 4th. The shares were sold at an average price of $222.92, for a total transaction of $89,168.00. Following the transaction, the director now owns 25,067 shares in the company, valued at $5,587,935.64. This trade represents a 1.57 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This trade represents a 12.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,621 shares of company stock worth $3,441,063. Corporate insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

Several research firms recently commented on CME. Oppenheimer increased their target price on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a report on Thursday, October 24th. Morgan Stanley lifted their price objective on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday, October 17th. Royal Bank of Canada restated a “sector perform” rating and set a $235.00 price target on shares of CME Group in a research report on Thursday, October 24th. Citigroup boosted their price objective on CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a research report on Thursday, October 24th. Finally, Piper Sandler lifted their target price on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research note on Monday, October 28th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, CME Group has an average rating of “Hold” and a consensus price target of $224.47.

CME Group Price Performance

CME stock opened at $229.04 on Monday. The firm has a 50-day moving average of $223.64 and a 200 day moving average of $211.08. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market cap of $82.54 billion, a P/E ratio of 24.08, a PEG ratio of 5.28 and a beta of 0.55. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $230.74.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the prior year, the company earned $2.25 EPS. The business’s revenue was up 18.4% compared to the same quarter last year. On average, sell-side analysts forecast that CME Group Inc. will post 10.22 EPS for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be given a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.01%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio is currently 48.37%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.